Myovant Sciences

Biotechnology ResearchCalifornia, United States51-200 Employees

Based in Brisbane, California, the organization operates in biotechnology research with a focus on developing therapies for women's health and prostate cancer. Its work targets conditions such as uterine fibroids, endometriosis, infertility, and prostate cancer, aiming to improve treatment options for those affected. Recent notes indicate the entity has transitioned within Sumitomo Pharma's corporate structure, with Myovant Sciences Inc. now represented by Sumitomo Pharma America and its European affiliate designated as Sumitomo Pharma Switzerland. As a mid-sized biopharmaceutical company, it emphasizes science-driven drug development in areas of high unmet need. The Brisbane base situates the company within the San Francisco Bay Area region, reflecting its role in a broader, global network.

Sign up for free to view info

Email Format Employee directory